Chiron delivers innovative and valuable products to protect human health by advancing pioneering science across the landscape of biotechnology. The company works to deliver on the limitless promise of science and make a positive difference in people's lives.

Angiotech Pharmaceuticals, Inc. is a specialty pharmaceutical and medical device company that discovers, develops and markets technologies primarily focused on acute and surgical applications. The Company generates its revenue through the sales of medical products and components, as well... more

Merck & Co., Inc. (Merck) is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of products to improve human and animal health. The Company’s operations are principally managed on a products basis and comprises of two business... more

Genentech, Inc. (Genentech) is a biotechnology company that discovers, develops, manufactures and commercializes pharmaceutical products to treat patients with unmet medical needs. It commercializes multiple biotechnology products and also receives royalties from companies that are... more

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and... more

Aventis (NYSE: AVE) is dedicated to improving life by treating and preventing human disease through the discovery and development of innovative prescription drugs for important therapeutic areas as well as human vaccines. Aventis Pasteur is the vaccine division within Aventis. In 2001,... more

Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other healthcare-related products. During the year ended December 31, 2007, the Company had three segments: Pharmaceuticals,... more

Novartis AG provides healthcare solutions that address the evolving needs of patients and societies.

AstraZeneca PLC discovers, develops, manufactures and markets prescription pharmaceuticals, biologics and vaccines for principal areas of healthcare, including cardiovascular, gastrointestinal, neuroscience, oncology, respiratory and inflammation, and infection. The Company's products... more

ImClone Systems Incorporated (ImClone) is a biopharmaceutical company that develops a portfolio of targeted biologic treatments designed to address the medical needs of patients with cancer. The Company focuses on two systems for treating cancer: growth factor blockers and angiogenesis... more

Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc., and a controlling interest in Matrix Laboratories Limited, India. Mylan develops, licenses, manufactures, markets... more

Gilead Sciences, Inc. (Gilead) is a biopharmaceutical company that discovers, develops and commercializes therapeutics in areas of unmet medical need. The Company has United States and international commercial sales operations, with marketing subsidiaries in Australia, Austria, Canada,... more

Celgene Corporation is an integrated biopharmaceutical company. The Company is primarily engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory-related diseases. The Company’s lead product is REVLIMID (lenalidomide) and... more

Biogen Idec Inc. is engaged in the development, manufacturing, and commercialization of therapies. The Company’s products address diseases such as multiple sclerosis, lymphoma and rheumatoid arthritis. The Company has four products: AVONEX (interferon beta-1a), RITUXAN (rituximab),... more

CuraGen Corporation (CuraGen) is a biopharmaceutical development company engaged in developing therapeutics for the treatment of cancer. The Company is focused on advancing its cancer treatments, belinostat and CR011-vcMMAE, through clinical development and toward commercialization. In... more

IVAX Corporation, headquartered in Miami, Florida, discovers, develops, manufactures, and markets branded and brand equivalent (generic) pharmaceuticals and veterinary products in the U.S. and internationally.

Cephalon, Inc. is an international biopharmaceutical company engaged in the discovery, development and marketing of products to treat human diseases. The Company’s focuses its efforts in four core therapeutic areas: central nervous system (CNS) disorders, pain, cancer and addiction. In... more

Exelixis, Inc. is a biotechnology company engaged in the development of differentiated pharmaceutical products for the treatment of cancer and other serious diseases. Exelixis has a pipeline of compounds in various stages of development that will potentially treat cancer, renal disease... more

OxiGene, Inc. is a clinical-stage, biopharmaceutical company developing therapeutics to treat cancer and eye diseases. The Company’s primary focus is the development and commercialization of product candidates referred to as vascular disrupting agents (VDAs) that selectively disrupt... more

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. The Company has three... more

YM BioSciences Inc. (YM BioSciences) is engaged in the licensing and commercialization of drug products and technologies from original research. The Company is advancing two late-stage products: nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor... more

Adherex Technologies Inc. a biopharmaceutical company focused on cancer therapeutics with preclinical and clinical product candidates. The Company has three product candidates in the clinical stage of development. Eniluracil is a dihydropyrimidine dehydrogenase (DPD) inhibitor that was... more

Telik, Inc. is a biopharmaceutical company working to discover, develop and commercialize small molecule drugs to treat diseases. The Company discovered its product candidates using its drug discovery technology, Target-Related Affinity Profiling (TRAP). As of December 31, 2007, Telik has... more

Pharmion Corporation is a leading global oncology company focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international Markets. Pharmion has a number of products on the... more

Antisoma plc (Antisoma) is a United Kingdom-based biopharmaceutical company, focused on developing products for the treatment of cancer. The Company has a portfolio of drugs in development, including small molecules, antibody-based therapies and a deoxyribonucleic acid (DNA) aptamer.... more

Array BioPharma Inc. (Array) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs. The Company’s drug development pipeline includes clinical candidates that are designed to treat patients afflicted with cancer,... more

OSI Pharmaceuticals, Inc. (OSI) is a biotechnology company primarily focused on the discovery, development and commercialization of molecular targeted therapies addressing unmet medical needs in oncology, diabetes and obesity. The Company's primary focus is oncology and its flagship... more

Mayne Pharma is a leading international pharmaceutical organisation providing innovative and cost effective products. Built on a heritage of 150 years of pharmaceutical excellence and represented in more than 50 countries, our intimate knowledge of local markets allows us to provide... more

Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that harness the immune system to fight cancer. Dendreon’s most advanced product candidate is Provenge (sipuleucel-T), an active cellular immunotherapy... more

Cytogen Corporation of Princeton, NJ is a product-driven, oncology-focused biopharmaceutical company. Cytogen markets proprietary and licensed oncology products through its in-house specialty sales force: Quadramet® (a skeletal targeting therapeutic radiopharmaceutical for the relief of... more

GPC Biotech AG is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of anticancer drugs. Its lead product candidate is satraplatin, a platinum-based compound intended for use as a chemotherapy treatment. Unlike other platinum-based drugs,... more

MethylGene Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutics for cancer. As of December 31, 2007, the Company is running multiple Phase I, Phase I/II, and Phase II clinical trials with its compound MGCD0103, an HDAC oncology... more

Bioniche Life Sciences Inc. is a Canadian biopharmaceutical company engaged in the research, development, manufacturing and commercialization of human and animal health products and technologies worldwide. Headquartered in Belleville, Ontario, the Company has offices and manufacturing... more

Sunesis Pharmaceuticals, Inc. (Sunesis) is a clinical-stage biopharmaceutical company. The Company focuses on the discovery, development and commercialization of small molecule therapeutics for use in oncology and other diseases. As of December 31, 2007, the Company was advancing three... more

MannKind Corporation (MannKind) is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. As of December 31, 2007, the Company's lead investigational product candidate, the Technosphere... more

Bioxel Pharma Inc. is a biopharmaceutical company focused on the manufacture and distribution of taxane pharmaceutical molecules, including paclitaxel and docetaxel, as well as their starting materials 9-DHB and 10-DAB. It is also developing semi-synthetic paclitaxel and Docetaxel. It... more

EntreMed, Inc. (EntreMed) is a clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells and the blood vessels that nourish them. The Company focused on developing drugs that are safe and convenient, and provide the potential for... more

SuperGen, Inc. is a pharmaceutical company dedicated primarily to the discovery, development and commercialization of therapies to treat patients with cancer. The Company acquires products that were developed by other companies and applies additional developmental effort to expand sales... more

BioCryst Pharmaceuticals, Inc. (BioCryst) is a biotechnology company that designs, optimizes and develops drugs that block key enzymes involved in cancer, viral infections and autoimmune diseases. It integrates the necessary disciplines of biology, crystallography, medicinal chemistry and... more

Cyclacel is a biopharmaceutical company that designs and develops small molecule drugs that act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. The Company's discovery engines integrate cell cycle biology... more

Allos Therapeutics, Inc. is a biopharmaceutical company that is focused on developing and commercializing small molecule drugs for the treatment of cancer. The Company’s lead product candidate, PDX (pralatrexate) an antifolate is in Phase 2 trial in patients with relapsed or refractory... more

ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company’s lead products, which are in clinical-stage testing, consist of ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase; ARQ 501, an... more

Genta Incorporated (Genta) is a biopharmaceutical company engaged in pharmaceutical (drug) research and development. The Company focuses on the identification, development and commercialization of drugs for the treatment of cancer and related diseases. Genta’s research portfolio consists... more

TransMolecular, Inc. is a biotechnology company committed to discovering, developing, and commercializing novel, targeted therapies that promise to improve outcomes for gliomas, metastatic brain tumors, and other aggressive cancers with limited treatment options. Our mission: To extend... more

Celsion Corporation is a biotechnology company focused on developing drugs for the treatment of various cancer indications. The first of these development projects involves ThermoDox, a heat activated liposome containing doxorubicin. The Company plans to develop ThermoDox for multiple... more

NeoRx is a cancer therapeutics development company dedicated to the development and commercialization of oncology products that impact the lives of individuals afflicted with cancer and metastases. The Company currently is focusing its development efforts on picoplatin, a... more

DOR Biopharma, Inc. (DOR) is a research and development biopharmaceutical company focused on the development of oral therapeutic products intended for areas of unmet medical need, as well as therapeutic and vaccine products. The Company operates in two business segments: BioDefense and... more

Neopharm Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of drugs for the treatment of cancer and other diseases. The Company built its drug development program around two technology platforms: a tumor-targeting toxin platform and NeoLipid... more

Novogen Limited is an Australia-based company. The Company, along with its subsidiaries, is principally engaged in pharmaceutical research and development, and marketing of consumer healthcare products. The Company operates in two business segments: consumer healthcare, and pharmaceutical... more

Threshold Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of drugs targeting the microenvironment of solid tumors as treatments for patients living with cancer. The Company has three product candidates, for which it has exclusive worldwide... more